CEBPA and acute myeloid leukemia: The study of Shih revealed that the frequency of CEBPA gene mutations was 8% at the moment of MDS diagnosis and 12% at the progression from MDS to AML [69] and considered that CEBPA mutations might be involved in the pathogenesis of a subgroup of MDS cases with the progression of the disease [69].